** Shares of hydrogel developer Nexgel NXGL.O rise as much
as 15% to $2.34 after the bell
** Company expects Q3 revenue of $2.2 mln, vs analysts est.
of $2.09 mln, according to LSEG data
** Sees Q4 revenue of $2.6 mln, topping estimates of $2.47
mln
** NXGL posts preliminary Q2 revenue of $1.4 mln vs est.
$1.41 mln
** The outlook does not include revenue from supply deal
with AbbVie ABBV.N signed last year - Nexgel
** Up to last close, stock down 4.2% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))